XBiotech Inc. SEC filings XBIT
XBiotech Inc. has 407 filings in SEC EDGAR's recent list, going back to Dec 10, 2014. Its latest annual report, Form ARS, was filed on Oct 2, 2026 for the period ended Oct 2, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-I/A | Filing | Jun 20, 2023 | — |
| SC TO-I | Filing | May 17, 2023 | — |
| SC TO-I/A | Filing | Feb 19, 2020 | — |
| SC TO-I/A | Filing | Feb 13, 2020 | — |
| SC TO-I/A | Filing | Feb 13, 2020 | — |
| SC TO-I/A | Filing | Feb 5, 2020 | — |
| SC TO-I | Issuer tender offer statement | Jan 14, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 1, 2018 | — |
| CORRESP | Letter to the SEC | Sep 4, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2018 | — |
| CORRESP | Letter to the SEC | Jul 31, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2018 | — |
| EFFECT | Filing | Sep 1, 2016 | — |
| CORRESP | Letter to the SEC | Aug 30, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2016 | — |
| CT ORDER | Filing | Apr 15, 2015 | — |
| CERTNAS | Auto-generated paper document | Apr 14, 2015 | — |
| EFFECT | Filing | Apr 14, 2015 | — |
| 8-A12B | Form 8-a12b | Apr 14, 2015 | — |
| CORRESP | Letter to the SEC | Apr 10, 2015 | — |
| CORRESP | Letter to the SEC | Apr 10, 2015 | — |
| CORRESP | Letter to the SEC | Apr 9, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2015 | — |
| CORRESP | Letter to the SEC | Mar 27, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2015 | — |
| CORRESP | Letter to the SEC | Mar 20, 2015 | — |
| CORRESP | Letter to the SEC | Mar 10, 2015 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2015 | — |
| CORRESP | Letter to the SEC | Feb 2, 2015 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2015 | — |
| DRS | Filing | Dec 10, 2014 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XBIT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1626878
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.